1021 Quick Takes
BioCentury & Getty Images

Deals

Oct. 21 Quick Takes: Clear path for BMS in MyoKardia deal; plus Purdue settles, Actemra misses, Cara-Vifor, InCarda, Azitra, Zosano   

By Jeff Cranmer, Executive Editor and Paul Bonanos, Associate Editor
Oct 21, 2020 | 10:59 PM GMT
Updated on Oct 22, 2020 at 1:50 AM GMT

Scant competition ahead of BMS-MyoKardia deal
Although negotiations drove the takeout price for MyoKardia Inc. (NASDAQ:MYOK) up to $225 per share from an initial offer of $185 by Bristol Myers

Read the full 646 word article

How to gain access

Continue reading with a
two-week free trial.